Course of Obesity and Extreme Obesity in Adolescents
YES
3 other identifiers
observational
429
1 country
5
Brief Summary
The rate of adolescent extreme obesity is rapidly rising, and impacting quality of life, psychosocial situation, and health of the affected youth. However, as few of these adolescents seek medical care, little is known about the longitudinal course of adolescent extreme obesity. In this study, the investigators aim to provide structured care for adolescents with obesity and extreme obesity over a prolonged period of time, and to gain information on the course of obesity and the success of different treatment options. The study is a subproject of the "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care", short: "Youth with Extreme obesity Study (YES)", which aims at improving the medical care and social support structures for youth with obesity and extreme obesity in Germany. Obese youth and young adults (BMI ≥ 30kg/m2) between the ages of 14 and 24.9 years (initially up to 21 years) are eligible to participate. Participants will have a physical check-up every 12 months (initially every 6 months), complete questionnaires on their health, socioeconomic status and wellbeing, and are offered blood test and diagnostic procedures to assess comorbidities. Participants are offered support and guidance for social and vocational integration. The study will evaluate and inform treatment and support options for adolescents with extreme obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2012
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 20, 2012
CompletedFirst Posted
Study publicly available on registry
August 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedMay 8, 2024
May 1, 2024
11 years
July 20, 2012
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
adherence with structured care
The percentage of subjects that comply with the structured follow up program will be calculated once a year.
12 months after subject inclusion
Secondary Outcomes (12)
percentage of subjects that can be integrated into the job-market or into an apprenticeship training position
every 12 months for 9 years
percentage of subjects that undergo the recommended diagnostic procedures
every 12 months for 9 years
changes in somatic co-morbidities
every 12 months for 9 years
changes in psychiatric co-morbidities
every 12 months for 9 years
compliance with treatment of somatic co-morbidities
every 12 months for 9 years
- +7 more secondary outcomes
Study Arms (2)
adolescents with extreme obesity
BMI ≥35kg/m2
adolescents with obesity
BMI 30-34.9kg/m2
Eligibility Criteria
Subjects will be recruited from the general population through different healthcare- and non healthcare settings to ascertain the inclusion of treatment-seeking and non treatment-seeking individuals. Healthcare settings include university based obesity clinics, physician offices and health insurance agencies. Non-healthcare settings include schools, job centers, and employment agencies.
You may qualify if:
- BMI ≥ 30kg/m2
- sufficient German language skills
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof. Dr. Martin Wabitschlead
- University of Witten/Herdeckecollaborator
- Charite University, Berlin, Germanycollaborator
- University of Leipzigcollaborator
- Universität Duisburg-Essencollaborator
- Helmholtz Zentrum Münchencollaborator
Study Sites (5)
Ambulatory Obesity Program, Charité University, Berlin
Berlin, 13353, Germany
Vestische Kinderklinik, University of Witten/Herdecke
Datteln, Germany
University Duisburg-Essen
Essen, 45147, Germany
University Hospital Leipzig
Leipzig, 04103, Germany
Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic
Ulm, 89075, Germany
Related Publications (1)
Wabitsch M, Moss A, Reinehr T, Wiegand S, Kiess W, Scherag A, Holl R, Holle R, Hebebrand J. Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care, short: Youth with Extreme Obesity Study (YES). BMC Public Health. 2013 Aug 29;13:789. doi: 10.1186/1471-2458-13-789.
PMID: 23987123DERIVED
Related Links
Biospecimen
Samples of fasting plasma, serum, DNA, and urine will be retained.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Martin Wabitsch, Prof. Dr. med.
University of Ulm
- PRINCIPAL INVESTIGATOR
Susanna Wiegand, Dr. med.
Charite University, Berlin, Germany
- PRINCIPAL INVESTIGATOR
Thomas Reinehr, Prof. Dr. med.
University of Witten/Herdecke
- PRINCIPAL INVESTIGATOR
Johannes Hebebrand, Prof. Dr. med.
Universität Duisburg-Essen
- PRINCIPAL INVESTIGATOR
Wieland Kiess, Prof. Dr. med.
University of Leipzig
- PRINCIPAL INVESTIGATOR
Reinhard Holl, Prof. Dr. med.
University of Ulm
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Division Chief Pediatric Endocrinology and Diabetology
Study Record Dates
First Submitted
July 20, 2012
First Posted
August 10, 2012
Study Start
July 1, 2012
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
May 8, 2024
Record last verified: 2024-05